BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 32766134)

  • 41. Radiomics analysis of [
    Li Y; Zhang Y; Fang Q; Zhang X; Hou P; Wu H; Wang X
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2599-2614. PubMed ID: 33416951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
    He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
    Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and Validation of a Radiomics Model Based on
    Xue B; Jiang J; Chen L; Wu S; Zheng X; Zheng X; Tang K
    Front Oncol; 2021; 11():740111. PubMed ID: 34765549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Zheng Z; Wang J; Tan W; Zhang Y; Li J; Song R; Xing L; Sun X
    Eur J Radiol; 2023 Aug; 165():110933. PubMed ID: 37406583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [
    Yang M; Li X; Cai C; Liu C; Ma M; Qu W; Zhong S; Zheng E; Zhu H; Jin F; Shi H
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38127071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Non-Invasive Radiomic Signature on CT Scans Predicts Response to Platinum-Based Chemotherapy and Is Prognostic of Overall Survival in Small Cell Lung Cancer.
    Jain P; Khorrami M; Gupta A; Rajiah P; Bera K; Viswanathan VS; Fu P; Dowlati A; Madabhushi A
    Front Oncol; 2021; 11():744724. PubMed ID: 34745966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body Composition and Radiomics From 18 F-FDG PET/CT Together Help Predict Prognosis for Patients With Stage IV Non-Small Cell Lung Cancer.
    Zhang Y; Tan W; Zheng Z; Wang J; Xing L; Sun X
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):906-912. PubMed ID: 37948365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction and verification of survival in patients with non-small-cell lung cancer based on an integrated radiomics nomogram.
    Li R; Peng H; Xue T; Li J; Ge Y; Wang G; Feng F
    Clin Radiol; 2022 Mar; 77(3):e222-e230. PubMed ID: 34974912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic ductal adenocarcinoma: a radiomics nomogram outperforms clinical model and TNM staging for survival estimation after curative resection.
    Xie T; Wang X; Li M; Tong T; Yu X; Zhou Z
    Eur Radiol; 2020 May; 30(5):2513-2524. PubMed ID: 32006171
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Liu F; Xiang Z; Li Q; Fang X; Zhou J; Yang X; Lin H; Yang Q
    Clin Radiol; 2024 Jan; 79(1):e147-e155. PubMed ID: 37884401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment
    Choi JH; Choi JY; Woo SK; Moon JE; Lim CH; Park SB; Seo S; Ahn YC; Ahn MJ; Moon SH; Park JM
    J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A nomogram based on pretreatment radiomics and dosiomics features for predicting overall survival associated with esophageal squamous cell cancer.
    Kawahara D; Nishioka R; Murakami Y; Emoto Y; Iwashita K; Sasaki R
    Eur J Surg Oncol; 2024 Jun; 50(7):108450. PubMed ID: 38843660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Value of
    Luo Y; Huang Z; Gao Z; Wang B; Zhang Y; Bai Y; Wu Q; Wang M
    Korean J Radiol; 2024 Feb; 25(2):189-198. PubMed ID: 38288898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive Power of a Radiomic Signature Based on
    Li X; Yin G; Zhang Y; Dai D; Liu J; Chen P; Zhu L; Ma W; Xu W
    Front Oncol; 2019; 9():1062. PubMed ID: 31681597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Prognostic Model of Non-Small Cell Lung Cancer With a Radiomics Nomogram in an Eastern Chinese Population.
    Wang L; Liu A; Wang Z; Xu N; Zhou D; Qu T; Liu G; Wang J; Yang F; Guo X; Chi W; Xue F
    Front Oncol; 2022; 12():816766. PubMed ID: 35774128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of programmed death-1 expression status in non-small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram.
    Tian Q; Jia JY; Qin C; Zhou H; Zhou SY; Qin YH; Wu YY; Shi J; Duan SF; Feng F
    Clin Radiol; 2024 May; ():. PubMed ID: 38876960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by
    Li J; Ge S; Sang S; Hu C; Deng S
    Front Oncol; 2021; 11():789014. PubMed ID: 34976829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer.
    Cai D; Duan X; Wang W; Huang ZP; Zhu Q; Zhong ME; Lv MY; Li CH; Kou WB; Wu XJ; Gao F
    Front Mol Biosci; 2020; 7():613918. PubMed ID: 33490106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.